Current Role of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) in Non-Small Cell Lung Cancer (NSCLC): Which Patients and Why

Last Modified: October 8, 2004

Share article

Conference Dates: December 4, 2004
Conference Location: Chicago, IL

Sponsoring Group:

Conference Web Page URL:

Topics Covered: Overview of EGFR Small-Molecule TKIs, Update on Recent Clinical Data for Small-Molecule TKIs, Second-Line Options for the Treatment of NSCLC, Clinical Variables of Patient Benefit: Who Should We Be Treating?, EGFR Small-Molecule TKIs and Rash: What Does it Mean?, Somatic Mutations and Response to EGFR Small-Molecule TKIs, Case Studies

Conference Objectives:

Who Should Attend: This activity is designed primarily for medical oncologists and other healthcare professionals interested in the treatment of cancer.

Conference Agenda:

Registration Information: To register for this meeting, please visit the conference website at or e-mail

Continuing Education: Yes

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More